norlestrin
combination of ethinyl estradiol & norethindrone acetate
Networked: 6
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
1. | Metrorrhagia (Spotting)
11/01/1979
- " The rate of breakthrough bleeding associated with Ovral use in the 1st 3 cycles (16.6%) was significantly (P .05) lower than that associated with using either Norinyl or Norlestrin (46% and 51.7%, respectively). " 05/26/1977
- " A double-blind crossover study of 480 women taking either Ovral, Norinyl, or Norlestrin was conducted to determine the effects of missing 1 contraceptive tablet in the pill sequence on the incidence of breakthrough bleeding. " 01/01/1976
- " Ovral provides more sustained endometrial control than Norinyl and Norlestrin, however, as indicated by its lower probability of breakthrough bleeding on the day a contraceptive tablet is missed and by its later onset of withdrawal bleeding." 01/01/1976
- " An analysis of the data shows that the normal chance of breakthrough bleeding on a particular day when one oral contraceptive tablet is not missed on the previous day is 0.017, 0.022, and 0.022 for Ovral, Norinyl, Norlestrin users, but the chance on the day after a contraceptive tablet is missed increased by 13 to 16 times for each of the three OCs. "
|
2. | Stroke (Strokes)
|
3. | Low Vision (Subnormal Vision)
|
4. | Shock
|
5. | Paralysis (Palsy)
|
|
Related Drugs and Biologics
Related Therapies and Procedures